MDI-1228_mesylate ophthalmic solution

MDI-1228 mesylate · Shanghai Medinno Pharmaceutical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MDI-1228_mesylate ophthalmic solution, covering 2024-07-09 to 2024-07-09. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MDI-1228_mesylate Ophthalmic Solution in Healthy Adults [Phase 1]